Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E David

Showing results (931-940 of 1,174) with videos related to

Pageof 118
Sort By:
Journal of Neurology|March 16, 2007
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECTSanjeet Pakrasi, Sean J Colloby, Michael J Firbank, et al.
BMC Developmental Biology|May 15, 2008
The transcription factor Nfix is essential for normal brain developmentChristine E Campbell, Michael Piper, Céline Plachez, et al.
Cancer Research|April 19, 2006
Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancerDominique S Michaud, Sarah E Daugherty, Sonja I Berndt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
A prospective study of lycopene and tomato product intake and risk of prostate cancerVictoria A Kirsh, Susan T Mayne, Ulrike Peters, et al.
European Urology|December 8, 2009
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristicsBertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, et al.
World Journal of Surgery|November 9, 2000
Lymphatic mapping and sentinel node biopsy of operable breast cancerJ F Rodier, T Routiot, H Mignotte, et al.
Metabolism: Clinical and Experimental|August 11, 2016
Validation of a metabolite panel for early diagnosis of type 2 diabetesTonia C Carter, Dietrich Rein, Inken Padberg, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Aging Cell|June 5, 2009
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancerLisa Mirabello, Wen-Yi Huang, Jason Y Y Wong, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancerAl B Barqawi, Ruslan Turcanu, Eduard J Gamito, et al.
Pageof 118

Showing results (931-940 of 1,174) with videos related to

Sort By:
Pageof 118
Journal of Neurology|March 16, 2007
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECTSanjeet Pakrasi, Sean J Colloby, Michael J Firbank, et al.
BMC Developmental Biology|May 15, 2008
The transcription factor Nfix is essential for normal brain developmentChristine E Campbell, Michael Piper, Céline Plachez, et al.
Cancer Research|April 19, 2006
Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancerDominique S Michaud, Sarah E Daugherty, Sonja I Berndt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
A prospective study of lycopene and tomato product intake and risk of prostate cancerVictoria A Kirsh, Susan T Mayne, Ulrike Peters, et al.
European Urology|December 8, 2009
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristicsBertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, et al.
World Journal of Surgery|November 9, 2000
Lymphatic mapping and sentinel node biopsy of operable breast cancerJ F Rodier, T Routiot, H Mignotte, et al.
Metabolism: Clinical and Experimental|August 11, 2016
Validation of a metabolite panel for early diagnosis of type 2 diabetesTonia C Carter, Dietrich Rein, Inken Padberg, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Aging Cell|June 5, 2009
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancerLisa Mirabello, Wen-Yi Huang, Jason Y Y Wong, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancerAl B Barqawi, Ruslan Turcanu, Eduard J Gamito, et al.
Pageof 118